Stran & Company (SWAG) Stock Price
Stran & Company Price
Revenue has compounded at 25.2% per year over the past 6 years to 116.19 M USD. Earnings per share have declined at 26.6% per year over the last 2 years. Stran & Company's net margin stands at -0.6%, down from 0.6% several years earlier. Analysts set a median price target of 4.59 USD, implying 240.0% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Stran & Company stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Stran & Company business model & stock analysis
Frequently asked questions about Stran & Company
Analysts currently set an average price target of 4.59 USD for the Stran & Company stock (median: 4.59 USD), implying +240.0 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Stran & Company stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Stran & Company share trades at 1.20 EUR (1.35 USD).
The Stran & Company share (SWAG) is listed on 3 stock exchanges, including: NASDAQ (STRN), Frankfurt (S9H.F), München (S9H.MU).
The revenue cannot currently be calculated for Stran & Company.
The profit cannot currently be calculated for Stran & Company.
The P/E ratio cannot be calculated for Stran & Company at the moment.
The P/S cannot be calculated for Stran & Company currently.
The Eulerpool Quality Score for Stran & Company is 2/10.
The ISIN of Stran & Company is US86260J1025. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Stran & Company is A3C7H6. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Stran & Company is SWAG. The ticker symbol is used to trade Stran & Company shares on the stock exchange.
Stran & Company stock
Stran & Company Peer Group
Stran & Company Ticker
Stran & Company FIGI
All fundamentals and in-depth analysis of Stran & Company
Our stock analysis for Stran & Company stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stran & Company. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.